Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Genetics of glioblastoma: a window into its imaging and histopathologic variability.

Belden CJ, Valdes PA, Ran C, Pastel DA, Harris BT, Fadul CE, Israel MA, Paulsen K, Roberts DW.

Radiographics. 2011 Oct;31(6):1717-40. doi: 10.1148/rg.316115512. Review.

PMID:
21997991
2.

Emerging insights into the molecular and cellular basis of glioblastoma.

Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, Chin L, Hahn WC.

Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112. Review.

3.

Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy.

de Groot J, Reardon DA, Batchelor TT.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e71. Review.

4.

Using the molecular classification of glioblastoma to inform personalized treatment.

Olar A, Aldape KD.

J Pathol. 2014 Jan;232(2):165-77. doi: 10.1002/path.4282. Review.

5.

Epidermal growth factor receptor as a therapeutic target in glioblastoma.

Kalman B, Szep E, Garzuly F, Post DE.

Neuromolecular Med. 2013 Jun;15(2):420-34. doi: 10.1007/s12017-013-8229-y. Review.

PMID:
23575987
6.

Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.

Onishi M, Kurozumi K, Ichikawa T, Date I.

Neurol Med Chir (Tokyo). 2013;53(11):755-63. Review.

7.

[Angiogenesis and anti-angiogenic strategies for glioblastoma].

de Boüard S, Guillamo JS.

Bull Cancer. 2005 Apr;92(4):360-72. Review. French.

8.

Antiangiogenic therapy for glioblastoma.

Gerstner ER, Batchelor TT.

Cancer J. 2012 Jan-Feb;18(1):45-50. doi: 10.1097/PPO.0b013e3182431c6f. Review.

9.

Therapeutic targeting of VEGF in the treatment of glioblastoma.

Robles Irizarry L, Hambardzumyan D, Nakano I, Gladson CL, Ahluwalia MS.

Expert Opin Ther Targets. 2012 Oct;16(10):973-84. doi: 10.1517/14728222.2012.711817. Review.

PMID:
22876981
10.

Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.

Zhang M, Ye G, Li J, Wang Y.

Brain Tumor Pathol. 2015 Oct;32(4):229-36. doi: 10.1007/s10014-015-0233-5. Review.

PMID:
26437643
11.

Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.

Chinot OL.

Expert Rev Anticancer Ther. 2012 Nov;12(11):1413-27. doi: 10.1586/era.12.128. Review.

PMID:
23249106
12.

Vascular Magnetic Resonance Imaging in Brain Tumors During Antiangiogenic Therapy--Are We There Yet?

Gerstner ER, Emblem KE, Sorensen GA.

Cancer J. 2015 Jul-Aug;21(4):337-42. doi: 10.1097/PPO.0000000000000128. Review.

PMID:
26222087
13.

Antiangiogenic therapies in glioblastoma multiforme.

McNamara MG, Mason WP.

Expert Rev Anticancer Ther. 2012 May;12(5):643-54. doi: 10.1586/era.12.35. Review.

PMID:
22594899
14.

Current role of anti-angiogenic strategies for glioblastoma.

Thomas AA, Omuro A.

Curr Treat Options Oncol. 2014 Dec;15(4):551-66. doi: 10.1007/s11864-014-0308-2. Review.

PMID:
25173555
15.

The role of avastin in the management of recurrent glioblastoma.

Sweet JA, Feinberg ML, Sherman JH.

Neurosurg Clin N Am. 2012 Apr;23(2):331-41, x. doi: 10.1016/j.nec.2012.02.001. Review.

PMID:
22440876
16.

Angiogenesis in glioblastoma multiforme: navigating the maze.

Linkous AG, Yazlovitskaya EM.

Anticancer Agents Med Chem. 2011 Oct;11(8):712-8. Review.

PMID:
21707499
17.

Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies.

Agnihotri S, Burrell KE, Wolf A, Jalali S, Hawkins C, Rutka JT, Zadeh G.

Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):25-41. doi: 10.1007/s00005-012-0203-0. Review.

PMID:
23224339
18.

Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.

Nana AW, Yang PM, Lin HY.

Asian Pac J Cancer Prev. 2015;16(16):6813-23. Review.

19.

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.

Miletic H, Niclou SP, Johansson M, Bjerkvig R.

Expert Opin Ther Targets. 2009 Apr;13(4):455-68. doi: 10.1517/14728220902806444 . Review.

PMID:
19335067
20.

Molecular pathology of malignant gliomas.

Louis DN.

Annu Rev Pathol. 2006;1:97-117. Review.

PMID:
18039109
Items per page

Supplemental Content

Support Center